- Home
- CUE vs ORMP Comparison
CUE vs ORMP Comparison
Compare CUE & ORMP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | CUE | ORMP |
|---|---|---|
| Founded | 2014 | 2002 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 233.5M | 170.3M |
| IPO Year | 2017 | 2010 |
Fundamental Metrics
Financial Performance| Metric | CUE | ORMP |
|---|---|---|
| Price | $38.06 | $4.66 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $120.00 | N/A |
| AVG Volume (30 Days) | 140.7K | ★ 191.6K |
| Earning Date | 05-13-2026 | 05-14-2026 |
| Dividend Yield | N/A | ★ 6.51% |
| EPS Growth | 61.11 | ★ 412.50 |
| EPS | N/A | ★ 2.76 |
| Revenue | ★ $27,466,000.00 | $2,000,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $1.69 |
| Revenue Growth | ★ 195.75 | 49.25 |
| 52 Week Low | $0.17 | $2.09 |
| 52 Week High | $45.50 | $5.47 |
Technical Indicators
Market Signals| Indicator | CUE | ORMP |
|---|---|---|
| Relative Strength Index (RSI) | 69.70 | 47.92 |
| Support Level | $24.35 | $3.91 |
| Resistance Level | $41.42 | $5.10 |
| Average True Range (ATR) | 3.24 | 0.18 |
| MACD | 1.23 | -0.06 |
| Stochastic Oscillator | 86.62 | 21.31 |
Price Performance
Historical ComparisonAbout CUE Cue Biopharma Inc.
Cue Biopharma Inc is a clinical-stage therapeutics company focused on advancing a robust portfolio of potentially transformative therapies aimed at enabling functional cures across immunological disorders. Its product pipeline includes CUE-221, an anti-IgE antibody candidate being developed for allergic diseases. The company has also developed the Immuno-STAT platform for targeting disease-related T cells and is developing CUE-401, an IL-2 and TGF-B therapeutic candidate for autoimmune diseases.
About ORMP Oramed Pharmaceuticals Inc.
Oramed Pharmaceuticals Inc is a pharmaceutical company that is engaged in the research and development of pharmaceutical solutions with a technology platform that allows for the oral delivery of therapeutic proteins. The company has developed an oral dosage form intended to withstand the harsh environment of the gastrointestinal tract and effectively deliver active insulin or other proteins. Its product pipeline includes ORMD-0801 for Diabetes, ORMD-0801 for NASH, and ORMD 0901.